About
Small Molecule DNA repair Inhibitors
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (3)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
170
By Phase
PHASE2: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06315491Lead Sponsor
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
PHASE2Recruiting
40 participants
Started: Sep 25, 2024 · Completed: Oct 31, 2025
NCT04902872Lead Sponsor
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
PHASE1/PHASE2Active, not recruiting
130 participants
Started: May 3, 2021 · Completed: Jun 30, 2025
Locations (1)
Headquarters
New Haven, CT, United States
Map
Loading map...